These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 29085213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ, Mao H, Shrestha A, Tan YQ, Ma WJ, Yang Q, Wang JK, Cheng NS, Li FY.
    World J Gastroenterol; 2016 Feb 28; 22(8):2601-10. PubMed ID: 26937148
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
    Peng D, Lu J, Hu H, Li B, Ye X, Cheng N.
    J Gastrointest Surg; 2020 Feb 28; 24(2):330-340. PubMed ID: 30671792
    [Abstract] [Full Text] [Related]

  • 5. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
    Li O, Yi W, Yang P, Guo C, Peng C.
    Acta Cir Bras; 2019 Apr 29; 34(4):e201900409. PubMed ID: 31038586
    [Abstract] [Full Text] [Related]

  • 6. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G, Bednarsch J, Czigany Z, Lurje I, Schlebusch IK, Boecker J, Meister FA, Tacke F, Roderburg C, Den Dulk M, Gaisa NT, Bruners P, Neumann UP.
    Eur J Surg Oncol; 2019 Aug 29; 45(8):1468-1478. PubMed ID: 31053477
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hilar cholangiocarcinoma: Value of high-resolution enhanced magnetic resonance imaging for preoperative evaluation.
    Xin Y, Liu Q, Zhang J, Lu J, Song X, Zhan H, Chen X, Cao Z, Li Y, Huang Z.
    J Cancer Res Ther; 2020 Aug 29; 16(7):1634-1640. PubMed ID: 33565510
    [Abstract] [Full Text] [Related]

  • 12. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
    Cannon RM, Brock G, Buell JF.
    HPB (Oxford); 2012 Feb 29; 14(2):142-9. PubMed ID: 22221577
    [Abstract] [Full Text] [Related]

  • 13. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ, Yang FC, Qin YS, Jin J, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2018 Apr 29; 17(2):155-162. PubMed ID: 29636302
    [Abstract] [Full Text] [Related]

  • 14. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    Tang Z, Yang Y, Zhao Z, Wei K, Meng W, Li X.
    Medicine (Baltimore); 2018 Aug 29; 97(34):e11999. PubMed ID: 30142840
    [Abstract] [Full Text] [Related]

  • 15. [Klatskin's tumors].
    Bertelsen CA, Burcharth F.
    Ugeskr Laeger; 2005 Apr 04; 167(14):1525-30. PubMed ID: 15887750
    [No Abstract] [Full Text] [Related]

  • 16. [New criteria of radical surgery and long-term outcomes of hilar cholangiocarcinoma management].
    Kovalenko YA, Vishnevsky VA, Chzhao AV, Zharikov YO.
    Khirurgiia (Mosk); 2018 Apr 04; (8):4-11. PubMed ID: 30113586
    [Abstract] [Full Text] [Related]

  • 17. A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma.
    Ding G, Yang Y, Cao L, Chen W, Wu Z, Jiang G.
    World J Surg Oncol; 2015 Mar 11; 13():99. PubMed ID: 25889726
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW, Cheung TT, She WH, Chok KSH, Chan ACY, Dai WC, Chiu WH, Lo CM.
    World J Surg; 2018 Mar 11; 42(3):823-834. PubMed ID: 28905105
    [Abstract] [Full Text] [Related]

  • 19. Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy.
    Ji GW, Zhu FP, Wang K, Jiao CY, Shao ZC, Li XC.
    J Gastrointest Surg; 2017 Apr 11; 21(4):666-675. PubMed ID: 28168674
    [Abstract] [Full Text] [Related]

  • 20. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
    Chen P, Li B, Zhu Y, Chen W, Liu X, Li M, Duan X, Yi B, Wang J, Liu C, Luo X, Li X, Li J, Liang L, Yin X, Wang H, Jiang X.
    Oncotarget; 2016 Jun 14; 7(24):37319-37330. PubMed ID: 27144432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.